GlassScriptPhysician profile
Wilfredo Nicolas Herrera
NPI 1992140677
$2,509.92
in general payments reported to CMS, 2019-2025
15 companies · $1,910 in 2025
The $1,910 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $199 · 2021: $184 · 2024: $43.95 · 2025: $1,910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $393 · Food and Beverage: $60.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $393.18 |
| Food and Beverage | $60.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,950.33 | 2024-2025 | |
| Abbvie INC. | $169.88 | 2020-2021 | |
| Duchesnay USA Incorporated | $86.31 | 2019 | |
| Avion Pharmaceuticals | $59.03 | 2019-2020 | |
| Exeltis, USA INC. | $56.46 | 2019-2021 | |
| Hologic Sales and Service, LLC | $36.87 | 2020 | |
| Nevro Corp. | $26.63 | 2019 | |
| Vertical Pharmaceuticals, LLC | $21.49 | 2019 | |
| Coopersurgical, INC. | $20.86 | 2021 | |
| Roche Diagnostics Corporation | $20.69 | 2021 | |
| Medicem INC. | $16.66 | 2020 | |
| Amgen INC. | $15.38 | 2020 | |
| Mylan Pharmaceuticals INC. | $13.93 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.61 | 2021 | |
| Organon LLC | $3.79 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilfredo Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.